Sidestream dark field videomicroscopy for in vivo evaluation of vascularization and perfusion of mammary tumours in HER2/neu transgenic mice

Clin Exp Pharmacol Physiol. 2015 Feb;42(2):225-9. doi: 10.1111/1440-1681.12343.

Abstract

Angiogenesis plays a key role in tumour growth and the formation of metastases. Angiogenesis inhibitors and antivascular agents may prove useful in the treatment of breast cancer. A comprehensive characterization of the vasculature and perfusion of mammary tumours is a prerequisite for developing new specific drugs. We used sidestream dark field videomicroscopy to evaluate in vivo the vascular network of spontaneous mammary tumours in HER2/neu transgenic mice. The tumour masses showed higher vessel density compared with the healthy mammary gland (median (interquartile range) total vessel density 16.8 (13.4-20.5) vs 9.1 (8.1-10.9) mm/mm(2), respectively; P < 0.001). Tumor vessel density was reduced in mice treated with the anti-angiogenesis agent berberine, 12.1 (10.6-13.1) mm/mm(2). Sidestream dark field imaging is a versatile technique that may be useful for understanding the role of angiogenesis in the progression of breast cancer and its relationship with outcome. It may represent a valuable tool for dynamic monitoring of the effects of new anti-angiogenesis therapies.

Keywords: angiogenesis; breast cancer; sidestream dark field videomicroscopy.

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Animals
  • Berberine / pharmacology
  • Female
  • Mammary Glands, Animal / pathology
  • Mammary Neoplasms, Animal / genetics
  • Mammary Neoplasms, Animal / pathology*
  • Mice
  • Mice, Transgenic / genetics
  • Mice, Transgenic / physiology*
  • Microscopy, Video / methods
  • Neovascularization, Pathologic / genetics
  • Neovascularization, Pathologic / pathology*
  • Rats
  • Receptor, ErbB-2 / genetics*

Substances

  • Angiogenesis Inhibitors
  • Berberine
  • Receptor, ErbB-2